NLRP3 and type 2 diabetes mellitus: These results also suggest that enhanced NLRP3 inflammasome activation, which may be caused by Kir6.1 downregulation, is partially responsible for the development of insulin resistance in db/db mice, a genetically manipulated type 2 diabetic mouse model.